Blood Transfusion Diagnostics Market Trends

  • Report ID: 4481
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Blood Transfusion Diagnostics Market Trends

Growth Drivers

  • Higher Number of People in Need of Dialysis- Dialysis is a kidney failure treatment that filters the blood to remove unwanted toxins, waste products, and excess fluids. When the kidneys fail, the body may struggle to clean the blood and keep the system chemically balanced. This is estimated to boost the blood transfusion diagnostics market during the forecast period. Globally, approximately 5-10 million people need dialysis or transplantation. Moreover, the prevalence of chronic kidney disorder is nearly 10% in men and around 11% in women.
  • Growing Prevalence of Chronic Disease – Chronic diseases such as cancer, cardiovascular diseases, leukemia, and other autoimmune diseases may require a blood transfusion. According to the World Health Organization, chronic cardiovascular disease is the leading cause of death in the world. additionally, around 18 million people died of cardiovascular disease.
  • Need to Fill the Blood Shortage Caused During Pandemic - Blood shortages have been caused by COVID-19's impact on supply chains and blood donation networks. This is especially concerning during emergencies since operations and emergency medical treatment frequently require blood. The market for blood transfusion diagnostics may expand as a result of the growing need for diagnostic tools and tests to check for these diseases. During COVID-19, the activity of blood donation decreased by around 40% to 67%, which caused a huge shortage of blood in the entire world and the number of blood donors in various countries decreased by about 20-30%.
  • Increased Cases of Road Accidents – Road accidents often lead to urgent emergency room (ER) visits, which may require blood for transfusion immediately. By the report of the World Health Organization, around 1.3 million people, every day dies in road accidents.

 Challenges

  • Shortage of Technologists to Perform Automated Autotransfusion - Advanced systems such as nucleic acid amplification test, and centrifugal machines used to separate blood cells requires skilled professionals, therefore, the lack of expert professionals is hampering the market growth.
  • Lack of appropriate Infrastructure
  • High Cost of Instruments, Tests & Treatment Required for Blood Transfusions

Blood Transfusion Diagnostics Market: Key Insights

Base Year

2022

Forecast Year

2023-2033

CAGR

~4%

Base Year Market Size (2022)

~USD 4 Billion

Forecast Year Market Size (2033)

~USD 9 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

3.9%

Base Year Market Size (2024)

USD 4.31 billion

Forecast Year Market Size (2037)

USD 7.09 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4481
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of blood transfusion diagnostics is estimated at USD 4.58 billion.

The blood transfusion diagnostics market size was over USD 4.31 billion in 2024 and is anticipated to cross USD 7.09 billion by 2037, growing at more than 3.9% CAGR during the forecast period i.e., between 2025-2037. Growing cases of COVID-19, rising road accidents, a dearth of blood donations, and a higher number suffering from kidney issues and chronic disease will boost the market growth.

North America industry is poised to account for largest revenue share of 41% by 2037, driven by higher number of road accidents taking place in the region.

The major players in the market are Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample